[go: up one dir, main page]

PE20081577A1 - Derivados de sulfonamida ciclicos como inhibidores de la recaptacion de monoamina - Google Patents

Derivados de sulfonamida ciclicos como inhibidores de la recaptacion de monoamina

Info

Publication number
PE20081577A1
PE20081577A1 PE2007001770A PE2007001770A PE20081577A1 PE 20081577 A1 PE20081577 A1 PE 20081577A1 PE 2007001770 A PE2007001770 A PE 2007001770A PE 2007001770 A PE2007001770 A PE 2007001770A PE 20081577 A1 PE20081577 A1 PE 20081577A1
Authority
PE
Peru
Prior art keywords
alkyl
recaptation
monoamine
inhibitors
sulfonamide derivatives
Prior art date
Application number
PE2007001770A
Other languages
English (en)
Inventor
Andrew Fensome
Joel Adam Goldberg
Casey Cameron Mccomas
Charles William Mann
Edward George Melenski
Joseph P Sabatucci
Richard Page Woodworth
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20081577A1 publication Critical patent/PE20081577A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE REFIERE A DERIVADOS DE SULFONAMIDA CICLICOS DE FORMULA (I), EN DONDE m ES DE 0 A 4; n ES DE 0 A 2; p ES DE 0 A 1; q ES DE 1 A 2; v ES DE 0 A 2; X ES C(R11)2, N(R12), O u S(O)v; Y ES C(R11)2, N(R12) O >C=C(R17)2; R1 ES ARILO O HETEROARILO SUSTITUIDO CON R5; R2 ES H, ALQUILO(C1-C6), ENTRE OTROS; R3 ES H, ALQUILO(C1-C6), ALCANOL(C1-C6), ENTRE OTROS; O R2 Y R3 JUNTOS AL N AL QUE ESTAN UNIDOS FORMAN UN MONO O BICICLICO HETEROCICLICO DE 3 A 12 ATOMOS; R4 ES H, ALQUILO(C1-C6), ARILO SUSTITUIDO CON R8; ARILALQUILO(C1-C6), ENTRE OTROS; R9 ES INDEPENDIENTEMENTE ALQUILO(C1-C6), ALCOXI, HALO, ENTRE OTROS; R13 ES H, ALQUILO(C1-C8), HALURO, HIDROXI, O ARILO SUSTITUIDO; R15 ES H, ALQUILO(C1-C4) O HALURO. SON SELECCIONADOS: 3-(2,2-DIOXIDO-1-FENIL-3,4-DIHIDRO-1H-2,1-BENZOTIAZIN-3-IL)-N-METILPROPAN-1-AMINA, 1-FENIL-3-(3-PIRROLIDIN-1-ILPROPIL)-3,4-DIHIDRO-1H-2,1-BENZOTIAZINA 2,2-DIOXIDO, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION, ESTOS COMPUESTOS SON INHIBIDORES DE LA RECAPTACION DE MONOAMINA, SIENDO UTILES EN EL TRATAMIENTO DE TRASTORNOS DE DEPRESION, TRASTORNOS DE COMPORTAMIENTO ENDOGENO, TRASTORNO COGNICITIVO, SINTOMAS VASOMOTRICES, DISFUNCION SEXUAL O AFECCIONES DE DOLOR
PE2007001770A 2006-12-12 2007-12-12 Derivados de sulfonamida ciclicos como inhibidores de la recaptacion de monoamina PE20081577A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86964206P 2006-12-12 2006-12-12

Publications (1)

Publication Number Publication Date
PE20081577A1 true PE20081577A1 (es) 2008-11-28

Family

ID=39345330

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001770A PE20081577A1 (es) 2006-12-12 2007-12-12 Derivados de sulfonamida ciclicos como inhibidores de la recaptacion de monoamina

Country Status (6)

Country Link
US (1) US20080171737A1 (es)
AR (1) AR064319A1 (es)
CL (1) CL2007003591A1 (es)
PE (1) PE20081577A1 (es)
TW (1) TW200831476A (es)
WO (1) WO2008073956A2 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005079726A1 (en) 2004-02-23 2005-09-01 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
EP3936180B1 (en) 2004-04-02 2023-11-29 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
EP2051762B1 (en) 2006-07-14 2020-03-11 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
US10258757B2 (en) 2008-05-12 2019-04-16 Fisher & Paykel Healthcare Limited Patient interface and aspects thereof
US10792451B2 (en) 2008-05-12 2020-10-06 Fisher & Paykel Healthcare Limited Patient interface and aspects thereof
US11660413B2 (en) 2008-07-18 2023-05-30 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
WO2010041966A1 (en) 2008-10-10 2010-04-15 Fisher & Paykel Healthcare Limited Nasal pillows for a patient interface
EP3741418B1 (en) 2009-11-18 2024-05-08 Fisher & Paykel Healthcare Limited Nasal interface
US9561338B2 (en) 2010-10-08 2017-02-07 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
CN102464627A (zh) * 2010-11-10 2012-05-23 上海药明康德新药开发有限公司 丙烯基-1,3-磺内酰胺的制备方法
US8895547B2 (en) 2011-03-08 2014-11-25 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120052A1 (de) * 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120053A1 (de) * 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
AU2012241516B2 (en) 2011-04-15 2016-06-16 Fisher & Paykel Healthcare Limited Interface comprising a rolling nasal bridge portion
US10603456B2 (en) 2011-04-15 2020-03-31 Fisher & Paykel Healthcare Limited Interface comprising a nasal sealing portion
KR102136431B1 (ko) 2012-05-11 2020-07-21 싱크로니시티 파마, 인크. 크립토크롬 조절제로서의 카르바졸-함유 술폰아미드
EP3967353A1 (en) 2012-08-08 2022-03-16 Fisher & Paykel Healthcare Limited Mask and headgear system
AU2013313717B2 (en) 2012-09-04 2018-04-12 Fisher & Paykel Healthcare Limited Valsalva mask
AU2013318206B2 (en) 2012-09-20 2018-07-26 Temple University - Of The Commonwealth System Of Higher Education Substituted alkyl diaryl derivatives, methods of preparation and uses
TWI690521B (zh) 2014-04-07 2020-04-11 美商同步製藥公司 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
CN112121269B (zh) 2014-08-25 2024-08-06 费雪派克医疗保健有限公司 呼吸面罩及其相关部分、部件或子组件
ES2762748T3 (es) 2015-05-22 2020-05-25 Basf Se Beta-naftoletersulfonatos, procedimiento para su preparación y su uso como mejoradores de brillo
WO2018007323A1 (en) 2016-07-04 2018-01-11 Bayer Cropscience Aktiengesellschaft Benzosultams and analogues and their use as fungicides
USD823455S1 (en) 2017-02-23 2018-07-17 Fisher & Paykel Healthcare Limited Cushion assembly for breathing mask assembly
USD824020S1 (en) 2017-02-23 2018-07-24 Fisher & Paykel Healthcare Limited Cushion assembly for breathing mask assembly
USD823454S1 (en) 2017-02-23 2018-07-17 Fisher & Paykel Healthcare Limited Cushion assembly for breathing mask assembly
CN111559990B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种小分子噁噻嗪类衍生物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3041336A (en) * 1958-10-01 1962-06-26 Norwich Pharma Co 3-oxo-1.2.6-thiadiazine-1.1-dioxides
US3303190A (en) * 1965-03-11 1967-02-07 Smith Kline French Lab Novel dihydro-2, 1-benzothiazine-2, 2-dioxide compounds
DE1811717A1 (de) * 1968-11-29 1970-06-11 Bayer Ag 2,4-Dicyano-6-nitrophenyl-Derivate
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines
US7414052B2 (en) * 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
WO2006000902A1 (en) * 2004-06-25 2006-01-05 Pfizer Products Inc. Dihydrobenzofuran compounds and uses thereof
US20060252818A1 (en) * 2005-05-06 2006-11-09 Neurocrine Biosciences, Inc. Monoamine re-uptake inhibitors and methods relating thereto

Also Published As

Publication number Publication date
US20080171737A1 (en) 2008-07-17
WO2008073956A2 (en) 2008-06-19
TW200831476A (en) 2008-08-01
WO2008073956A3 (en) 2008-07-24
AR064319A1 (es) 2009-03-25
CL2007003591A1 (es) 2008-02-29

Similar Documents

Publication Publication Date Title
PE20081577A1 (es) Derivados de sulfonamida ciclicos como inhibidores de la recaptacion de monoamina
BR122012009489B8 (pt) processo para produzir 2-etóxi-1-{[2’-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso
BRPI0418368A (pt) derivados de (3-oxo-3,4-dihidro-quinoxalin2-ilamino)-benzamida e compostos afins, como inibidores de glicogênio fosforilase para o tratamento de diabetes e obesidade
PE20081475A1 (es) Arilamidas sustituidas por tiazol u oxazol
PE20120219A1 (es) Inhibidores de beta-secretasa
AR066881A1 (es) Derivados de oxadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de trastornos asociados con la disfuncion del glutamato.
NO20085269L (no) 2-tioksantinderivater som fungerer som MPO-inhibitorer
MA31084B1 (fr) Derives de piperidine agonistes de gpcr
EA200970461A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ
AR057855A1 (es) Derivados de pirazina y composicion farmaceutica
EA201490902A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
TW200637550A (en) Thiazole-4-carboxamide derivatives as mGluR5 antagonists
IL189191A0 (en) Thiazolyl piperidine derivatives useful as h3 receptor modulators
EA201071019A1 (ru) Кристаллические формы производных фениламинопиримидина
CO6251235A2 (es) Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
PE20090362A1 (es) Derivados de piperidina/piperazina como moduladores de dgat
PE20070833A1 (es) Compuestos de pirimidinil benzotiofeno
PE20090712A1 (es) Moduladores de la gamma secretasa
AR044906A1 (es) Derivados de difenilpiridina, su preparacion y su aplicacion en terapeutica
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
PE20091018A1 (es) Novedosos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo y composicion farmaceutica de los mismos para el tratamiento de la eyaculacion prematura
BRPI0406500A (pt) processo farmacêutico e compostos preparados pelo mesmo
AR067937A1 (es) Derivados de indol -2- ona disustituidos en 3, su preparacion y su aplicacion en terapeutica
AR046753A1 (es) Derivados de benzoxazina y usos de los mismos
PE20090295A1 (es) Derivados de espirociclopropilpiperidina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal